GSK's asthma drug Nucala wins FDA's approval to treat 'smoker's lung'
1. GSK's asthma drug approved for treating 'smoker's lung' by FDA. 2. This approval could expand GSK's market presence in respiratory treatments.
FAQ
Why Bullish?
FDA approvals often lead to increased sales potential. Historical examples include Vertex's price surge post-FDA approval for cystic fibrosis drugs.
How important is it?
FDA approval can significantly influence GSK's market value through potential revenue increases in an expanding market segment.
Why Long Term?
New indications for existing drugs can result in sustained revenue growth. For instance, companies like Eli Lilly saw long-term revenue growth following similar approvals.